GL1X · GenesisL1 explorer

Research workbench

Crystal structure of thioredoxin E101G mutant

Analyse Crystal structure of thioredoxin E101G mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HR0
Type
protein
Length
215 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thioredoxin
UniProt
C3SKR2
Ligands
CU
Pockets
1 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThioredoxinprotein10834% helix, 27% strandC3SKR2
BThioredoxinprotein10733% helix, 26% strandC3SKR2

Ligands and binding sites

  • CU · Copper (II) ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11090.490.8020empty

Interfaces

1 interface between chains.

  • A–B · 423 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 5HR0 · Crystal structure of thioredoxin E101G mutant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.